News

Factbox-Lilly's weight-loss drug launch in India to energize rivals eyeing mega market

Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug: NOVO NORDISK The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ingredient in Wegovy is semaglutide, which is likely to go off-patent in 2026 in India. Wegovy and Lilly's Mounjaro belong to the same class of treatments called GLP-1 agonists, which soared into popularity globally triggering a shortage of supply.

Trump Says Fed Should Cut Rates as Tariff Push Heats Up

(Bloomberg) -- President Donald Trump said the Federal Reserve should cut interest rates, splitting with the US central bank as officials weigh the economic cost of his tariff push. Most Read from BloombergDespite Cost-Cutting Moves, Trump Plans to Remake DC in His StyleAmtrak CEO Departs Amid Threats of a Transit Funding PullbackNew York Subway Ditches MetroCard After 32 Years for Tap-And-GoNYC Plans for Flood Protection Without Federal FundsThe Scary Thing About the Wildfire That Was Stopped“T